Michael Mawhorter, MD
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 65.9% of it on its own, with 14 other manufacturers making up the rest. That places this record below the midpoint for urology clinicians in OH, where the typical reported total is $2,547.
Across 52 payments — averaging $44.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Sumitomo Pharma America, Inc.$210
- Johnson & Johnson$126
- Endo USA, Inc.$116
- Urogen Pharma, Inc.$68
- Convatec Inc.$45
- plus $228 from 9 others
What the payments were for
- Travel & lodging$1,12148%
- Food & beverage$1,13349%
- Education$683%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $1,530 |
| Sumitomo Pharma America, Inc. | 11 | $210 |
| Johnson & Johnson | 4 | $126 |
| Endo USA, Inc. | 6 | $116 |
| Urogen Pharma, Inc. | 3 | $68 |
| Convatec Inc. | 2 | $45 |
| Axonics, Inc. | 2 | $41 |
| Laborie Medical Technologies Corp. | 1 | $30 |
| Bayer | 1 | $26 |
| Teleflex LLC | 1 | $26 |
| Procept Biorobotics Corporation | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Civco Medical Instruments | 1 | $23 |
| Photocure Inc | 1 | $18 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lumenis Pulse 120H$1,297
How this compares
$2,322 in reported general payments places this provider in the 45th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 40 | $560 |
| Finasteride | 52 | $455 |
| Ciprofloxacin Hcl | 24 | $122 |
Paid to pharmacies, not to this prescriber.
Other urology in Parma
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Benjamin MartinGahanna$205K
- Ruben OlivaresCleveland$184K
- Abhinav SidanaCincinnati$174K
- Raymond RackleyCleveland$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.